Ch Biomedical (USA)
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4134 Pacific Coast Hwy, Torrance, Califo...Phone Number
(877) 203-3858Website
www.chbiomedical.comRevenue
<$5 MillionIndustry
About Ch Biomedical (USA)
Suzhou Tongxin Medical Technology Co., Ltd. specializes in the research, development, production, and sales of innovative ventricular assist devices (VADs), also known as artificial hearts. Founded in 2008, the company aims to lead advancements in global artificial heart technology, providing exceptional services to healthcare professionals and patients suffering from heart failure. Their flagship product, the Cizhi VAD, is designed to significantly improve the quality of life and longevity for heart failure patients. The company is committed to enhancing the health and happiness of a broader range of patients and their families.Explore more
Ch Biomedical (USA) Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Ch Biomedical (USA)
Compare insights from companies similar to Ch Biomedical (USA), focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ch Biomedical (USA) Tech Stack
A closer look at the technologies used by Ch Biomedical (USA)
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ch Biomedical (USA)
Sign Up For FreeTo access detailed company insights
Suzhou Tongxin Medical Technology Co., Ltd. specializes in the research, development, production, and sales of innovative ventricular assist devices (VADs), also known as artificial hearts. Founded in 2008, the company aims to lead advancements in global artificial heart technology, providing exceptional services to healthcare professionals and pat... Read More
